Department of Hepato-Gastroenterology, CHU Hassan II, Fez, Morocco.
World Journal of Advanced Research and Reviews, 2025, 25(01), 2104-2107
Article DOI: 10.30574/wjarr.2025.25.1.0221
Received on 12 December 2024; revised on 24 January 2025; accepted on 27 January 2025
Neuroendocrine carcinoma of the esophagus is a rare, highly aggressive malignancy characterized by rapid progression. The clinical picture is not very specific, ranging from simple abdominal discomfort to dysphagia with altered general condition.
Here, we present the case of a 65-year-old woman with a history of chronic gastroesophageal reflux disease, who presented with dysphagia, exploration of which revealed neuroendocrine carcinoma of the esophagus.
Due to its rarity, the treatment strategy is not yet standardized. Surgery combined with adjuvant therapy appears to be the best option for treating limited-stage esophageal neuroendocrine carcinoma.
Neuroendocrine Carcinoma of Esophagus; Dysphagia; Gastroesophageal Reflux Disease; Surgery
Preview Article PDF
Rajae Bounour, Yousra El Kirami, Dafrallah Benajeh and Hakima Abid. A rare entity: Neuroendocrine tumor of the esophagus about one case. World Journal of Advanced Research and Reviews, 2025, 25(01), 2104-2107. Article DOI: https://doi.org/10.30574/wjarr.2025.25.1.0221.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0